UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A collaborative approach in dementia care to improve clinical effectiveness and priorities for research through audit

International journal of palliative nursing, 2019-12, Vol.25 (12), p.588-595

2019

Volltextzugriff (PDF)

Bullying in the Police Service: Constructs and Processes

McIvor, Karen Maureen

2004

Volltextzugriff (PDF)

Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I

Human gene therapy, 2017-07, Vol.28 (7), p.576-587

2017

Volltextzugriff (PDF)

Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer

Human gene therapy, 2017-08, Vol.28 (8), p.626-638

2017

Volltextzugriff (PDF)

Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction

Human gene therapy, 2023-01, Vol.34 (1-2), p.8-18

2023

Volltextzugriff (PDF)

Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I

Frontiers in molecular neuroscience, 2021-05, Vol.14, p.618360-618360

2021

Volltextzugriff (PDF)

Prisoners' understanding and experiences of parole

Criminal behaviour and mental health, 2020-12, Vol.30 (6), p.321-330

2020

Volltextzugriff (PDF)

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt

PLoS medicine, 2010-05, Vol.7 (5), p.e1000270-e1000270

2010

Volltextzugriff (PDF)

Ultimate drivers of forced extra-pair copulations in birds lacking a penis: jackdaws as a case-study

Royal Society open science, 2024-03, Vol.11 (3), p.231226-20

2024

Volltextzugriff (PDF)

Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome

Molecular genetics and metabolism reports, 2023-03, Vol.34, p.100956-100956, Article 100956

2023

Volltextzugriff (PDF)

Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10

Molecular genetics and metabolism reports, 2020-09, Vol.24, p.100604-100604, Article 100604

2020

Volltextzugriff (PDF)

Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes

Frontiers in public health, 2022-10, Vol.10, p.1012835-1012835

2022

Volltextzugriff (PDF)

86. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System to Prevent the Onset of Neurologic Deficits in a Murine Model of Mucopolysaccharidosis Type II

Molecular therapy, 2016-05, Vol.24, p.S38-S38

2016

Volltextzugriff (PDF)

369. Therapeutic Effectiveness of AAV-Mediated Iduronidase Delivery to the CNS Following Intravenous Administration in a Murine Model of Mucopolysaccharidosis Type I

Molecular therapy, 2016-05, Vol.24, p.S148-S148

2016

Volltextzugriff (PDF)

Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

The Lancet. Psychiatry, 2024-09, Vol.11 (9), p.696-708

2024

Volltextzugriff (PDF)

369. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System of Mucopolysaccharidosis Type II Mice

Molecular therapy, 2015-05, Vol.23, p.S146-S146

2015

Volltextzugriff (PDF)

Neurologic improvement in a mouse model of Hunter syndrome (mucopolysaccharidosis type II) by treatment with AAV9 vector after the development of cognitive dysfunction

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S107-S108

2017

Volltextzugriff (PDF)

706. Non-Invasive Intranasal Administration of AAV9-Iduronidase Prevents Emergence of Neurologic Disease and Neurocognitive Dysfunction in a Murine Model of Mucopolysaccharidosis Type I

Molecular therapy, 2015-05, Vol.23, p.S281-S281

2015

Volltextzugriff (PDF)

Gene delivery and biodistribution following intravenous administration of AAV9/rh10 iduronidase in a murine model of MPS type I

Molecular genetics and metabolism, 2016-02, Vol.117 (2), p.S26-S26

2016

Volltextzugriff (PDF)

AAV9 mediated correction of iduronate-2-sulfatase deficiency in the central nervous system of mucopolysaccharidosis type II mice

Molecular genetics and metabolism, 2016-02, Vol.117 (2), p.S70-S70

2016

Volltextzugriff (PDF)

Intranasal gene delivery of AAV9 iduronidase: A non-invasive and effective gene therapy approach for prevention of neurologic disease in a murine model of mucopolysaccharidosis type I

Molecular genetics and metabolism, 2016-02, Vol.117 (2), p.S26-S26

2016

Volltextzugriff (PDF)

Relative effectiveness of different routes of AAV administration for gene therapy of mucopolysaccharidosis

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S93-S93

2017

Volltextzugriff (PDF)

2,6-Dithiopurine, a nucleophilic scavenger, protects against mutagenesis in mouse skin treated in vivo with 2-(chloroethyl) ethyl sulfide, a mustard gas analog

Toxicology and applied pharmacology, 2012-09, Vol.263 (2), p.203-209

2012

Volltextzugriff (PDF)

Evaluation of anesthesia residents using mannequin-based simulation: a multiinstitutional study

Anesthesiology (Philadelphia), 2002-12, Vol.97 (6), p.1434-1444

2002

Volltextzugriff (PDF)

Intrathecal and intranasal infusion of adeno-associated virus vector: non-invasive routes of administration achieving corrective levels of iduronidase expression throughout the brain for gene therapy of mucopolysaccharidosis type I

Molecular genetics and metabolism, 2014-02, Vol.111 (2), p.S75-S76

2014

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)
Dissertationen
(1)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(8)
Gene Therapy
(5)
Genetics & Heredity
(5)
Animals
(4)
Cognition
(4)
Female
(4)
Gene Transfer
(4)
Glycosaminoglycans
(4)
Male
(4)
Mice
(4)
Mucopolysaccharidosis
(4)
Aav
(3)
Biotechnology & Applied Microbiology
(3)
Brain
(3)
Central Nervous System
(3)
Central Nervous System - Metabolism
(3)
Enzymes
(3)
Gene Expression
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A collaborative approach in dementia care to improve clinical effectiveness and priorities for research through audit

Bullying in the Police Service: Constructs and Processes

Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I

Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer

Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction

Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I

Prisoners' understanding and experiences of parole

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt

Ultimate drivers of forced extra-pair copulations in birds lacking a penis: jackdaws as a case-study

Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome

Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10

Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes

86. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System to Prevent the Onset of Neurologic Deficits in a Murine Model of Mucopolysaccharidosis Type II

369. Therapeutic Effectiveness of AAV-Mediated Iduronidase Delivery to the CNS Following Intravenous Administration in a Murine Model of Mucopolysaccharidosis Type I

Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

369. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System of Mucopolysaccharidosis Type II Mice

Neurologic improvement in a mouse model of Hunter syndrome (mucopolysaccharidosis type II) by treatment with AAV9 vector after the development of cognitive dysfunction

706. Non-Invasive Intranasal Administration of AAV9-Iduronidase Prevents Emergence of Neurologic Disease and Neurocognitive Dysfunction in a Murine Model of Mucopolysaccharidosis Type I

Gene delivery and biodistribution following intravenous administration of AAV9/rh10 iduronidase in a murine model of MPS type I

AAV9 mediated correction of iduronate-2-sulfatase deficiency in the central nervous system of mucopolysaccharidosis type II mice

Intranasal gene delivery of AAV9 iduronidase: A non-invasive and effective gene therapy approach for prevention of neurologic disease in a murine model of mucopolysaccharidosis type I

Relative effectiveness of different routes of AAV administration for gene therapy of mucopolysaccharidosis

2,6-Dithiopurine, a nucleophilic scavenger, protects against mutagenesis in mouse skin treated in vivo with 2-(chloroethyl) ethyl sulfide, a mustard gas analog

Evaluation of anesthesia residents using mannequin-based simulation: a multiinstitutional study

Intrathecal and intranasal infusion of adeno-associated virus vector: non-invasive routes of administration achieving corrective levels of iduronidase expression throughout the brain for gene therapy of mucopolysaccharidosis type I

Suchergebnisse filtern